Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19,737 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data.
Yu S, Huang F, Fan Z, Xuan L, Nie D, Xu Y, Yang T, Wang S, Jiang Z, Xu N, Lin R, Ye J, Lin D, Sun J, Huang X, Wang Y, Liu Q. Yu S, et al. Among authors: yang t. J Hematol Oncol. 2020 Mar 12;13(1):18. doi: 10.1186/s13045-020-00859-5. J Hematol Oncol. 2020. PMID: 32164760 Free PMC article. Clinical Trial.
Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first complete remission: a prospective multicentre cohort study.
Yu S, Huang F, Wang Y, Xu Y, Yang T, Fan Z, Lin R, Xu N, Xuan L, Ye J, Yu W, Sun J, Huang X, Liu Q. Yu S, et al. Among authors: yang t. Leukemia. 2020 May;34(5):1433-1443. doi: 10.1038/s41375-019-0686-3. Epub 2019 Dec 12. Leukemia. 2020. PMID: 31831845 Clinical Trial.
Mesenchymal stem cells enhance the impact of KIR receptor-ligand mismatching on acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia.
Zhang Y, Zheng H, Ren J, Luo X, Zheng Z, Zheng J, Zheng X, Chen Y, Chen Z, Hu J, Yang T. Zhang Y, et al. Among authors: yang t. Hematol Oncol. 2021 Aug;39(3):380-389. doi: 10.1002/hon.2867. Epub 2021 Apr 13. Hematol Oncol. 2021. PMID: 33848027
Association of iKIR-mismatch model and donor aKIRs with better outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia.
Zhang Y, Ye C, Zhu H, Zhuang Y, Chen S, Weng Y, Ren J, Luo X, Zheng J, Zheng X, Li J, Lan L, Xie Y, Han Z, Hu J, Yang T. Zhang Y, et al. Among authors: yang t. Front Immunol. 2023 Jan 24;13:1091188. doi: 10.3389/fimmu.2022.1091188. eCollection 2022. Front Immunol. 2023. PMID: 36761162 Free PMC article.
[A Retrospective Study on the Efficacy and Safety of Idarubicin Combined with High-Dose Cytarabine Consolidation in Patients with Acute Myeloid Leukemia over 60 Years of Age in First Remission].
Cao J, Ye YZ, Zheng XY, Chen Y, Luo LT, Zheng J, Yang T, Hu JD. Cao J, et al. Among authors: yang t. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Jun;31(3):671-676. doi: 10.19746/j.cnki.issn.1009-2137.2023.03.009. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023. PMID: 37356925 Chinese.
19,737 results
You have reached the last available page of results. Please see the User Guide for more information.